GTS Securities’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-50,800
Closed -$5.61M 1675
2024
Q3
$5.61M Buy
50,800
+3,200
+7% +$335K 0.01% 821
2024
Q2
$4.68M Sell
47,600
-9,100
-16% -$927K 0.01% 897
2024
Q1
$6.34M Buy
56,700
+17,100
+43% +$1.85M 0.01% 715
2023
Q4
$3.99M Sell
39,600
-64,100
-62% -$6.36M 0.01% 1157
2023
Q3
$9M Buy
+103,700
New +$9.37M 0.02% 642

Other funds holding CAH

GTS Securities's CAH Position: Q1 2026 in Review

GTS Securities reduced its Cardinal Health (CAH) stake by 72% in Q1 2026, selling an estimated $549K and leaving 1,013 shares worth $214K. The position accounts for 0.01% of the portfolio, ranked #1322.

GTS Securities first reported a position in CAH in Q2 2023 and has held it in 9 quarters since. The position peaked at $2.47M in Q3 2023. 1,426 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • GTS Securities held 1,013 shares of Cardinal Health worth $214K as of Q1 2026.
  • GTS Securities sold 2,549 Cardinal Health shares in Q1 2026, an estimated $549K.
  • Cardinal Health made up 0.01% of GTS Securities's portfolio in Q1 2026, its #1322 holding.
  • GTS Securities first reported a position in Cardinal Health in Q2 2023 and has held it in 9 quarters since.
  • GTS Securities's Cardinal Health position peaked at $2.47M in Q3 2023.
  • 1,426 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.